martes, 1 de septiembre de 2020

The American public is worried that a coronavirus vaccine will be motivated by politics

D.C. Diagnosis
Nicholas Florko

The American public is worried that a coronavirus vaccine will be motivated by politics

For months, FDA officials, congressional lawmakers and public health experts have openly worried about whether Trump’s tendency to openly pressure the FDA to approve a coronavirus vaccine before the November election will increase vaccine hesitancy. 

And a new poll from STAT News and Harris Poll provides a fascinating — albeit complicated — answer to that question. The new poll finds that 78% percent of Americans worry the Covid-19 vaccine approval process is being driven more by politics than science and a whopping 83% worry about the eventual vaccine’s safety. However, people still seem eager to get the vaccine: 67% of those surveyed said they would get the vaccine as soon as it was available.

Curious how to improve vaccine hesitancy? Check out this largely overlooked, sweeping report, released last month, from an expert panel convened by Johns Hopkins University. Their overall recommendation: “Put people at the center” of any effort to promote vaccines. The group recommends that the federal government develop a nationwide strategy to promote the vaccine, and that state and local governments partner with local organizations to understand vaccine hesitancy in individual communities. They also suggest working with trusted community partners to disseminate “vaccine-affirming, personally relevant” messages.

Want evidence that the strategy works? Check out my colleague Amy Sokolow’s newest profile of a Baltimore pastor using the pulpit to promote vaccination among his largely Black congregation.

Another idea worth watching: Three senators have also introduced legislation they say would “improve public confidence in a potential vaccine.” The bill, from Sens. Maggie Hassan (D-N.H.), Mike Braun (R-Indiana) and Lisa Murkowski (R-Alaska) would require that expert CDC and FDA panels meet before the FDA approves a coronavirus vaccine. 

No hay comentarios: